Central sleep apnea: implications for congestive heart failure.

Area of Science:

• Cardiology
• Pulmonology
• Sleep Medicine

Background:

• Congestive heart failure (HF) is a prevalent and costly condition.
• Central sleep apnea (CSA), often presenting as Cheyne-Stokes respiration, frequently co-occurs with HF.
• Historically, CSA was viewed as a marker of cardiac disease, but the relationship may be bidirectional.

Purpose of the Study:

• To review the epidemiologic, pathophysiologic, diagnostic, and therapeutic aspects of CSA in patients with HF.
• To explore the potential pathophysiologic significance of CSA in HF outcomes.
• To discuss the implications of recent clinical trial results for CSA treatment in HF.

Main Methods:

• Review of existing literature on the association between HF and CSA.
• Analysis of observational data linking CSA, oxyhemoglobin desaturations, and sympathetic activity to HF.
• Evaluation of outcomes from large clinical trials investigating CSA therapy in HF patients.

Main Results:

• Observational data suggest CSA may negatively impact HF outcomes through mechanisms like repetitive oxyhemoglobin desaturations and increased sympathetic activity.
• The first large trial of continuous positive airway pressure (CPAP) for CSA in HF yielded disappointing results.
• The complex relationship between HF and CSA necessitates further investigation.

Conclusions:

• The bidirectional relationship between HF and CSA warrants further research.
• Future large-scale interventional trials are required to ascertain the role of CSA treatment in improving HF outcomes.
• A comprehensive understanding of CSA in HF is crucial for effective management.